- Acquired factor VIII inhibitor in a pacient with antiphospholipid syndrome and hereditary thrombophiliaPublication without faculty affiliation
- Today's view of hereditary thrombophilia2022 | First Faculty of Medicine
- The impact of hereditary thrombophilia on the incidence of postoperative venous thromboembolism in colorectal cancer patients: aprospective cohort study: Hereditary thrombophilia and VTE in colorectal cancer surgery2019 | First Faculty of Medicine, Faculty of Physical Education and Sport
- The impact of hereditary thrombophilia on the incidence of postoperative venous thromboembolism in colorectal cancer patients: a prospective cohort study: Hereditary thrombophilia and VTE in colorectal cancer surgery2019 | First Faculty of Medicine
- Hereditary thrombophilias - which of them should be diagnosed using genetic tests?2012 | First Faculty of Medicine
- Is screening for hereditary thrombophilia indicated in first early pregnancy loss?2012 | First Faculty of Medicine
- Comment on article Does heparin prevent adverse pregnancy outcomes associated with hereditary thrombophilia?2008 | Publication without faculty affiliation
- Pharmacological prophalyxis and treatment of thromboembolism in patients with herteditary thrombophilic status2019 | First Faculty of Medicine
- The frequencies of six important thrombophilic mutations in a population of the Czech Republic2014 | First Faculty of Medicine
- Early pregnancy loss and inherited thrombophilic states. +12009 | Publication without faculty affiliation
- Genetically-conditioned risk factors for thrombophilia in GPs2017 | First Faculty of Medicine
- Multiple thrombophilia mutations as a possible cause of premature myocardial infarction2017 | First Faculty of Medicine
- Congenital and acquired thrombophilias2021 | First Faculty of Medicine
- Questions about prophylaxis and treatment of venous thromboembolism in 20062006 | First Faculty of Medicine
- Analysis of risk factor : the rationale of the guildelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia2006 | First Faculty of Medicine
- Frequencies of the new thrombophilic mutations of antithrombin (SERPINC1) (IVS +141G>A), glycoprotein GPVI (Ser219Pro) and cytochrome CYP4V2 (Lys259Gln) in healthy middle-aged people in Central Bohemia2012 | First Faculty of Medicine
- Analysis of risk factors: The rationale of the guidelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia2006 | Second Faculty of Medicine
- Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAI-1 4G/5G and their combinations in a group of 1,450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)2012 | First Faculty of Medicine